Anemia Treatment Market Size to Reach US$ 14.9 Bn by 2028 | CAGR of 6.9% - Future Market Insights
According to a Future Market Insights (FMI) analysis, the Anaemia Treatment Market would exceed US$ 10.0 billion by 2022. More than 70% of anaemia treatment is sought for normocytic anaemia, with microcytic anaemia coming in second. According to a new research analysis by Future Market Insights, the condition as a result of one or more chronic diseases drives the majority of the demand for anaemia therapy. Get Full Access @ https://www.futuremarketinsights.com/reports/aemia-treatment-market One of the non-communicable chronic conditions responsible for the epidemiological transition of developing regions, chronic kidney disease (CKD) is a key factor fuelling demand for anemia treatment. Anemia treatment market is also receiving a strong impetus from the rising popularity of combination therapy. Increasing use of vitamin and iron supplements, antibiotics, metal chelating agents, and erythropoietin stimulating agents in combination therapy is cited as in important factor ...